Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.03 (-5.26%)
Close on Nov 18, 2026Market cap $3.25MP/E –Yield –
Imunon shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Imunon's shares outstanding was 5M at Mar 31, 2026. For fiscal 2025 it was 2M, up 93.2% from the year before. Over ten years it grew 43.6% a year on average. The highest annual figure on record is 9M in fiscal 2023.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2M | +93.2% |
| FY2024 | Dec 31, 2024 | 1M | -87.9% |
| FY2023 | Dec 31, 2023 | 9M | +26.6% |
| FY2022 | Dec 31, 2022 | 7M | +31.6% |
| FY2021 | Dec 31, 2021 | 5M | +154.7% |
| FY2020 | Dec 31, 2020 | 2M | +46.4% |
| FY2019 | Dec 31, 2019 | 1M | +24.2% |
| FY2018 | Dec 31, 2018 | 1M | +130.5% |
| FY2017 | Dec 31, 2017 | 1M | +311.4% |
| FY2016 | Dec 31, 2016 | 0M | +116.7% |
| FY2015 | Dec 31, 2015 | 0M | +18.1% |
| FY2014 | Dec 31, 2014 | 0M | +36.4% |
| FY2013 | Dec 31, 2013 | 0M | +75.1% |
| FY2012 | Dec 31, 2012 | 0M | +66.3% |
| FY2011 | Dec 31, 2011 | 0M | +69.0% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | 5M | +286.5% |
| Q4 FY2025 | Dec 31, 2025 | 3M | +124.4% |
| Q3 FY2025 | Sep 30, 2025 | 3M | +128.2% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +103.8% |
| Q1 FY2025 | Mar 31, 2025 | 1M | -86.2% |
| Q4 FY2024 | Dec 31, 2024 | 1M | -86.1% |
| Q3 FY2024 | Sep 30, 2024 | 1M | -86.2% |
| Q2 FY2024 | Jun 30, 2024 | 1M | -92.8% |
| Q1 FY2024 | Mar 31, 2024 | 9M | +32.4% |
| Q4 FY2023 | Dec 31, 2023 | 9M | +34.7% |
| Q3 FY2023 | Sep 30, 2023 | 9M | +62.5% |
| Q4 FY2022 | Dec 31, 2022 | 9M | +50.8% |
| Q3 FY2022 | Sep 30, 2022 | 7M | +23.0% |
| Q2 FY2022 | Jun 30, 2022 | 7M | +21.9% |
| Q1 FY2022 | Mar 31, 2022 | 6M | +30.6% |
| Q4 FY2021 | Dec 31, 2021 | 6M | +127.7% |
| Q3 FY2021 | Sep 30, 2021 | 6M | +153.7% |
| Q2 FY2021 | Jun 30, 2021 | 6M | +187.5% |
| Q1 FY2021 | Mar 31, 2021 | 4M | +156.9% |
| Q4 FY2020 | Dec 31, 2020 | 3M | +47.7% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +57.5% |
| Q2 FY2020 | Jun 30, 2020 | 2M | +45.0% |
| Q1 FY2020 | Mar 31, 2020 | 2M | +35.1% |
| Q4 FY2019 | Dec 31, 2019 | 2M | +43.2% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +21.7% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +16.1% |
| Q1 FY2019 | Mar 31, 2019 | 1M | +8.0% |
| Q4 FY2018 | Dec 31, 2018 | 1M | +20.0% |
| Q3 FY2018 | Sep 30, 2018 | 1M | +121.0% |
| Q2 FY2018 | Jun 30, 2018 | 1M | +120.3% |
| Q1 FY2018 | Mar 31, 2018 | 1M | +958.5% |
| Q4 FY2017 | Dec 31, 2017 | 1M | +639.5% |
| Q3 FY2017 | Sep 30, 2017 | 1M | +304.1% |
| Q2 FY2017 | Jun 30, 2017 | 1M | +367.4% |
| Q1 FY2017 | Mar 31, 2017 | 0M | +82.1% |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
| Q2 FY2016 | Jun 30, 2016 | 0M | – |
| Q1 FY2016 | Mar 31, 2016 | 0M | – |
See a number that looks wrong?